TG Therapeutics Inc (TGTX)
14.25
+0.15
(+1.06%)
USD |
NASDAQ |
Apr 23, 16:00
14.27
+0.02
(+0.14%)
After-Hours: 20:00
TG Therapeutics Total Assets (Quarterly): 329.59M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 329.59M |
| September 30, 2023 | 331.07M |
| June 30, 2023 | 220.85M |
| March 31, 2023 | 197.36M |
| December 31, 2022 | 193.57M |
| September 30, 2022 | 217.89M |
| June 30, 2022 | 251.67M |
| March 31, 2022 | 303.03M |
| December 31, 2021 | 379.63M |
| September 30, 2021 | 409.69M |
| June 30, 2021 | 481.40M |
| March 31, 2021 | 548.70M |
| December 31, 2020 | 625.64M |
| September 30, 2020 | 273.86M |
| June 30, 2020 | 294.62M |
| March 31, 2020 | 101.85M |
| December 31, 2019 | 163.01M |
| September 30, 2019 | 93.33M |
| June 30, 2019 | 106.58M |
| March 31, 2019 | 117.54M |
| December 31, 2018 | 83.62M |
| September 30, 2018 | 114.37M |
| June 30, 2018 | 140.72M |
| March 31, 2018 | 120.99M |
| December 31, 2017 | 97.38M |
| Date | Value |
|---|---|
| September 30, 2017 | 101.78M |
| June 30, 2017 | 101.20M |
| March 31, 2017 | 123.26M |
| December 31, 2016 | 54.78M |
| September 30, 2016 | 75.69M |
| June 30, 2016 | 94.80M |
| March 31, 2016 | 100.06M |
| December 31, 2015 | 113.47M |
| September 30, 2015 | 127.41M |
| June 30, 2015 | 123.61M |
| March 31, 2015 | 117.27M |
| December 31, 2014 | 86.75M |
| September 30, 2014 | 77.54M |
| June 30, 2014 | 56.30M |
| March 31, 2014 | 58.17M |
| December 31, 2013 | 48.11M |
| September 30, 2013 | 54.30M |
| June 30, 2013 | 17.86M |
| March 31, 2013 | 21.39M |
| December 31, 2012 | 22.07M |
| September 30, 2012 | 25.23M |
| June 30, 2012 | 26.53M |
| March 31, 2012 | 27.07M |
| December 31, 2011 | 14.54M |
| September 30, 2011 | 18.06M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
93.33M
Minimum
Sep 2019
625.64M
Maximum
Dec 2020
290.70M
Average
273.86M
Median
Sep 2020
Total Assets (Quarterly) Benchmarks
| Amicus Therapeutics Inc | 777.88M |
| Geron Corp | 394.08M |
| Editas Medicine Inc | 499.15M |
| G1 Therapeutics Inc | 121.54M |
| Mersana Therapeutics Inc | 226.06M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 169.08M |
| Shareholders Equity (Quarterly) | 160.50M |
| Debt to Equity Ratio | 0.6238 |
| Current Ratio | 5.918 |
| Net Debt Paydown Yield | -0.23% |